Xarelto® (rivaroxaban) is an anti-coagulant, or blood thinner, that was approved by the FDA in 2011 as alternative to Coumadin (warfarin). However, Xarelto carries a potentially deadly side effect: uncontrollable bleeding with no known antidote.
Xarelto is manufactured, developed, marketed, sold and/or promoted in the U.S. by industry giants, Bayer, Johnson & Johnson and Janssen Pharmaceutical. Xarelto has been widely prescribed since 2011 to patients with atrial fibrillation; pulmonary embolism; deep vein thrombosis; stroke; and patients who have recently undergone a knee or hip replacement surgery. Xarelto became immensely popular as it was marketed and promoted as having “no routine blood monitoring, no dietary restrictions, and no dosage adjustments, so patients could take just one pill a day.” The FDA deemed these statements in Xarelto print ads to be misleading. These statements are also dangerous and pose a threat to the safety of patients taking Xarelto, while at the same time allowing the makers of Xarelto to reap huge profits.
Numerous deaths and serious bleeding events have been linked to Xarelto. The dangerous and potentially deadly side effects of Xarelto include: gastrointestinal bleeding, rectal bleeding, brain hemorrhage, and other forms of serious, uncontrollable bleeding. Importantly, there is no publicly known antidote to reverse the bleeding caused by Xarelto.
If you or a loved one has suffered from serious internal bleeding or other side effects caused by Xarelto, please contact The D’Onofrio Firm at 215.923.1056, at once, for a free consultation with one of our attorneys.
For more information on the dangers of Xarelto and the conduct of Bayer, J&J and Janssen, please go to our partner firm, Jacobs & Crumplar, PA.